New Zealand markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
79.28+2.67 (+3.49%)
At close: 04:00PM EDT
79.41 +0.13 (+0.16%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 30.47B
Enterprise value 23.26B
Trailing P/E 7.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.07
Price/book (mrq)2.60
Enterprise value/revenue 4.66
Enterprise value/EBITDA 4.64

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 3-26.99%
S&P500 52-week change 323.01%
52-week high 3170.47
52-week low 362.55
50-day moving average 398.51
200-day moving average 3106.24

Share statistics

Avg vol (3-month) 33.82M
Avg vol (10-day) 33.79M
Shares outstanding 5384.4M
Implied shares outstanding 6384.4M
Float 8347.11M
% held by insiders 19.52%
% held by institutions 172.71%
Shares short (15 Aug 2024) 425M
Short ratio (15 Aug 2024) 46.18
Short % of float (15 Aug 2024) 48.56%
Short % of shares outstanding (15 Aug 2024) 46.50%
Shares short (prior month 15 Jul 2024) 422.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin -116.18%
Operating margin (ttm)-565.56%

Management effectiveness

Return on assets (ttm)-15.42%
Return on equity (ttm)-40.94%

Income statement

Revenue (ttm)5.05B
Revenue per share (ttm)13.22
Quarterly revenue growth (yoy)-29.90%
Gross profit (ttm)N/A
EBITDA -4.11B
Net income avi to common (ttm)-5.87B
Diluted EPS (ttm)-15.35
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.49B
Total cash per share (mrq)22.08
Total debt (mrq)1.27B
Total debt/equity (mrq)10.84%
Current ratio (mrq)4.09
Book value per share (mrq)30.50

Cash flow statement

Operating cash flow (ttm)-3.24B
Levered free cash flow (ttm)-2.35B